Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8351920 | 0.80 | GAA (0.48) | GAAALDH1A1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL14280871 | 0.77 | PKM (0.44) | GAAALDH1A1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL10955536 | 0.73 | ALDH1A1 (0.40) | GAAALDH1A1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL24137901 | 0.70 | LMNA (0.51) | GAAALDH1A1RAB9AHPGDHDAC3 | |
| SCHEMBL7175504 | 0.70 | PKM (0.54) | GAAALDH1A1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL5852846 | 0.70 | MAPT (0.46) | GAAALDH1A1NPC1AGTR1HDAC1 | |
| SCHEMBL28373892 | 0.70 | MAPT (0.46) | GAAALDH1A1NPC1AGTR1HDAC1 | |
| SCHEMBL41828 | 0.69 | ABAT (0.53) | GAAALDH1A1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL7785939 | 0.69 | ABAT (0.53) | GAAALDH1A1RAB9ASMN1; SMN2HPGD | |
| Hydrochloric Acid SCHEMBL3069393 | 0.69 | ABAT (0.53) | GAAALDH1A1RAB9ASMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10871496-B2 | Composite compound comprising upconverting nanoparticle and specific receptor | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2020-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10871496-B2 | Composite compound comprising upconverting nanoparticle and specific receptor | INSR, GPR119, HBG1 | GAA 747/4885ALDH1A1 1493/4885RAB9A 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.